Concepedia

Maria Victoria Burgess

MV

Statistics

Publications

5

Citations

627

H-Index

5

Active since

2018

Affiliations

Allergan (United States)(Current)

Case Western Reserve University

Stanford University

VA Palo Alto Health Care System

Maria Victoria Burgess is an author at Allergan (United States) specializing in clinical pharmacology, depression pharmacotherapy, and psychopharmacology.

Publications per year

2018–2024

5

Publications

5

Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

Willie Earley, Maria Victoria Burgess, Barbara Khan et al. · Bipolar Disorders · 2019 · 245 citations · Full text

, , +16

Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder

Eduard Vieta, Willie Earley, Maria Victoria Burgess et al. · International Clinical Psychopharmacology · 2018 · 190 citations · Full text

, , +16

Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study

Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda et al. · American Journal of Psychiatry · 2019 · 155 citations · Full text

, , +17

A pooled post hoc analysis evaluating the safety and tolerability of cariprazine in bipolar depression

Willie Earley, Maria Victoria Burgess, Ludmyla Rekeda et al. · Journal of Affective Disorders · 2019 · 27 citations · Full text

, , +17

Safety and Tolerability of Brexpiprazole in Adolescents With Schizophrenia: A Long-Term, Open-Label Study

S Atkinson, Alpesh Shah, Maria Victoria Burgess et al. · JAACAP Open · 2024 · 10 citations · Full text

, , +17

1–5 of 5